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The 1.85 AÊ Structure of Vaccinia Protein
VP39: A Bifunctional Enzyme That Participates
in the Modification of Both mRNA Ends
Alec E. Hodel,* Paul D. Gershon,³ Xuenong Shi,³ subunit of the heterodimeric vaccinia virus poly(A) poly-
merase (Moss et al., 1975; Gershon et al., 1991). Theand Florante A. Quiocho*²
*Howard Hughes Medical Institute poly(A) polymerase larger subunit, VP55, possesses the
poly(A) polymerase catalytic activity. In the absence of²Department of Biochemistry
Baylor College of Medicine VP39, VP55 polyadenylates the 39 ends of uridylate con-
taining RNA primers bimodally (Gershon and Moss,Houston, Texas 77030
³Institute of Biosciences and Technology 1992, 1993b): 30±35 nucleotides are added in an initiat-
ing processive burst, followed by an abrupt transitionDepartment of Biochemistry and Biophysics
Texas A&M University to a slow, nonprocessive mode of oligo(A) tail elonga-
tion. In the presence of VP39, this slow nonprocessiveHouston, Texas 77030
elongation of oligo(A) tails is converted to a much more
rapid, semiprocessive reaction (Gershon and Moss,
1993a).
Summary Here, we report the 1.85 AÊ X-ray crystal structure of
the AS11 mutant of VP39 (Schnierle et al., 1994; Shi et
VP39 is a bifunctional vaccinia virus protein that acts al., 1996) complexed with its AdoMet cofactor. AS11
as both an mRNA cap±specific RNA 29-O-methyltrans- contains three amino acid substitutions with respect
ferase and a poly(A) polymerase processivity factor. to wild-type VP39, namely R140A, K142A, and R143A.
Here, we report the 1.85 AÊ crystal structure of a VP39 Although defective in methyltransferase activity, AS11
variant complexed with its AdoMet cofactor. VP39 is wild type in its action as a polyadenylationprocessivity
comprises a single core domain with structural simi- factor. In contrast to AS11, wild-type VP39 could not be
larity to the catalytic domains of other methyltransfer- crystallized. Despite its structural similarity to prokary-
ases. Surface features and mutagenesis data suggest otic and eukaryotic methyltransferases, consistent with
two possible RNA-binding sites with novel underlying a possiblecoevolutionary relationship between poxvirus
architecture, one of which forms a cleft spanning the and cellular proteins, VP39 displays a novel architecture
region adjacent to the methyltransferase active site. for an RNA-binding protein. The structural data provide
This report provides a prototypic structure for an RNA a detailed picture of the bonding interactions between
methyltransferase, a protein that interacts with the VP39 and AdoMet. Furthermore, they facilitate modeling
mRNA 59 cap, and an intact poxvirus protein. of the interactions of single-stranded RNA with two sites
on the VP39 surface, consistent with the bifunctionality
of this unusual RNA-binding protein.Introduction
The poxviruses are large DNA viruses that replicate ex- Results and Discussion
clusively in the cytoplasm of eukaryotic cells. Their au-
tonomy from the host cell DNA replication and transcrip- The Overall Structure
VP39 is a compact single-domain protein with a typicaltional machinery requires that poxvirus genomes
encode counterparts to many of those host-cell factors a/b fold. The central portion of the polypeptide chain
folds into a core structure, in which a mixed seven-and enzymes that are normally sequestered in the nu-
cleus. Virus-encoded enzymes catalyze the production stranded twisted b-sheet structure is surrounded by
parallel a helices (Figure 1). This structure is reminiscentof unspliced mRNA with typical eukaryotic features,
such as a 59 cap structure and a 39 poly(A) tail (Moss, of the Rossmann fold/nucleotide-binding motif found in
the dinucleotide-binding domains of dinucleotide-bind-1990). Many of the factors and enzymes responsible
for vaccinia transcription and mRNA modification have ing proteins (Rossmann et al., 1974) and in the catalytic
domains of other methyltransferases (see below). Ap-been characterized (Moss, 1990) and have provided re-
vealing insights into cellular transcription and mRNA pended to the core are the N- and C-terminal regions
of VP39. These regions, which form a loop plus a shortprocessing functions (for review, see Moss et al., 1991).
VP39 is an z39 kDa vaccinia virus protein that partici- a helix (N terminus) and three a helices (C terminus),
combine to occlude one face of the core (Figure 1).pates in the maturation of both ends of nascent vaccinia
transcripts. At the 59 end, the protein acts as a cap- The structures of four AdoMet-dependent methyl-
transferases have previously been reported. The threespecific mRNA (nucleoside-29-O-)-methyltransferase
(Barbosa and Moss, 1978; Schnierle et al., 1992). In the prokaryotic enzymes, M. Hha I (Klimasauskas et al.,
1994), M. HaeIII (Reinisch et al., 1995), and M. TaqI (La-initial steps of mRNA cap synthesisÐi.e., guanylylation
and guanine-7-methylationÐa cap 0 structure (m7G bahn et al., 1994) are bilobal in architecture, possessing
separate catalytic and substrate recognition domains,(59)ppp(G/A)) is formed (Shuman and Moss, 1990). VP39
acts upon the cap 0 structure by methylating the ribose while the fourth, mammalian catechol O-methyltransfer-
ase (COMT; Vidgren et al., 1994), is a single domain29 OH of the first transcribed nucleotide in an S-adeno-
sylmethionine (AdoMet)-dependent manner, converting protein. The similarity in layout of secondary structure
elements between the mammalian COMT and the cata-cap 0 to the cap I (m7G(59)ppp(Gm/Am)) form. At the mRNA
39 end, VP39 acts in poly(A) tail elongation as the smaller lytic domains of two of the three prokaryotic enzymes
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one difference is notable: where b strands 5 and 6 of
the consensus are connected by an a helix (Figure 2,
helix E), the equivalent strands of the VP39 core (b5 and
b7) are connected by a short b strand (b6) together with
a long loop connecting strands b5 and b6.
The protein envelope resembles a highly oblate
sphere with one face bisected by a cleft (Figures 3A and
3D). The cleft face comprises the loops adjacent to the
C termini of each of the seven b strands, upon which
parallel ridges are formed from two surface features:
the long loop connecting strands b5 and b6, and helix
a1. The bound AdoMet molecule is positioned near the
center of the cleft face as depicted in Figures 3A, 3D,
and 3G. Traveling away from the AdoMet-binding site
and between the two parallel ridges, the cleft narrows
and deepens into a hydrophobic pocket lined with sol-
vent-exposed aromatic side chains, including those of
residues Y22 and F180 (Figure 3A). The face of the VP39
disk opposite the cleft face is formed from the loops
N-terminal to each of the seven b strands, and by theFigure 1. Ribbon Diagram Showing the Secondary Structure Ele-
ments of VP39 three C-terminal helices appended to the core structure.
Ball-and-stick representation is used for the AdoMet molecule. The Although this face has fewer surface features (Figure
protein is viewed from the side containing the AdoMet-binding site, 3C), a sizable patch of basic residues can be discerned,
i.e., parallel to the central seven-stranded b sheet. One side of the surrounded by several solvent-exposed aromatics do-
cleft is formed primarily from the C-terminal loops of the b sheet
nated from both the N-terminal loops (e.g., Y12 and F13)plus helix a1, the other side from the b5±b6 loop. The position of
and the C-terminal helices (e.g., Y264 and F265).the missing 142±147 loop, near the AdoMet-binding site, is indi-
Only 291 of the predicted 333 residues of AS11 werecated. The figure was created using the program MOLSCRIPT
(Kraulis, 1991). visible in electron density maps. Whereas density ex-
tended to the extreme N terminus of VP39, 36 C-terminal
residues were not visible. This invisible region corre-has facilitated the derivation of a consensus fold
sponds exactly with the 36 residue tail of VP39 which(Schluckebier et al., 1995). Despite the absence of any
was shown biochemically to be unnecessary for VP39detectable sequence similarity between VP39 and other
activity and also to be highly sensitive to proteolyticmethyltransferases, comparison of the structure of the
cleavage (Shi et al., 1996). The invisibility of the tail inVP39 core with the consensus structure reveals a very
high degree of structural conservation (Figure 2). Only electron density maps is consistent with its apparently
disordered, highly flexible coil conformation. Also miss-
ing from the maps were residues 142±147, which were
expected to connect b4 with a6, presumably forming
a six-residue loop. The lack of density for this region
suggests it is highly disordered in AS11, likely a result
of conformational flexibility.
Geometry of the AdoMet-Binding Site
As AdoMet was not explicitly added to AS11 during
crystallization, endogenous coenzyme apparently be-
came bound during expression of the protein in E. coli.
Using the refined apo-protein model, an Fo±Fc map re-
vealed the position of every nonhydrogen atom in Ado-
Met including its donor methyl (Figure 4). The bound
AdoMet and closely associated protein residues are
among the most highly ordered regions of the overall
(Figure 3 legend continued)
Figure 2. Topological Diagrams Comparing the Architecture of green. In (D), the green patches abutting AdoMet and below the
VP39 to That of Other Methyltransferases blue missing loop endpoints indicate the surface positions of substi-
tutions in mutants AS11 and SS4, respectively. The remaining twoThe secondary structure of VP39 (A) is shown along with the consen-
sus fold for the four structurally defined methyltransferases (B). green patches (abutting the active site and within the pocket) are
due to mutants AS14 and AS17, respectively (Schnierle et al., 1994,This seven-stranded a/b fold is shared by COMT and the catalytic
domains of M. HhaI, M. HaeIII, and M. TaqI (Labahn et al., 1994; Shi et al., 1996). In (C), Site B represents the location of a second
putative RNA-binding site on the flat face of VP39 (see text). Dia-Vidgren et al., 1994; Reinisch et al., 1995; Schluckebier et al., 1995;
Klimasauskas et al., 1994). Helices are shown as circles, strands as grams (G)±(I) show MOLSCRIPT representations of secondary struc-
ture features for each of the three views of VP39.triangles.
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Figure 3. The Surface of VP39 Viewed from Three Angles, Differing by Rotations of Approximately 908 about the Vertical Axis
(A, D, and G) The face containing the AdoMet-binding site. (B, E, and H) The side of the highly oblate sphere viewing along the cleft toward
the AdoMet-binding site. (C, F, and I) The flat face of VP39, i.e. the face opposite the cleft face. Images (A)±(C) show electrostatic potential
(w) at the protein surface (calculated by the program GRASP; Nicholls et al., 1991). The surface is colored red (negative potential due to acidic
side chains) or blue (positive potential due to basic side chains). Two contour levels in w are indicated by the intensity of surface coloration
(blue or red): |w| > 10 kT is darkest (where kT 5 .592 kcal/mol); 4 kT < |w| < 10 kT is lighter. |w| < 4 kT is not colored blue or red. Solvent-
exposed phenylalanine, tyrosine, and tryptophan side chains are colored green and labeled by residue number. These side chains were only
colored if more that 10% of their surface area was determined to be solvent accessible (calculated using the Connolly algorithm implemented
in XPLOR [BruÈ nger, 1992]). Images (D)±(F) show the surface locations of amino acid substitutions leading to defects in methyltransferase
activity without loss of adenylyltransferase-stimulatory activity (Schnierle et al., 1994; Shi et al., 1996). The region of VP39containing substitutions
leading to defects in binding to the terminal (m7G) nucleotide of the cap 0 structure (residues 32±46; Shi et al., 1996) is colored yellow (labeled
cap binding). The endpoints of the missing six-residue loop (residues S141 and P148) are colored blue. Solvent-exposed areas of AdoMet
are colored gold except for the donor methyl group, which is colored red. The position of the donor methyl group defines the active site
(marked active site). The hydrophobic pocket at the distal end of the cleft is labeled pocket. Surface changes resulting from those specifically
methyltransferase-defective mutants possessing either an unknown primary lesion or a defect in overall RNA binding are colored
(Figure 3 legend continued on previous page)
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Figure 4. Stereo Diagram Showing Electron Density at the AdoMet-Binding Site and the Interactions between AdoMet and Nearby Residues
of AS11
The Fo-Fc electron density map, contoured at 2.5 s, was calculated at 1.85 AÊ from a model that did not contain the AdoMet molecule. As
shown, the AdoMet molecule is clearly defined including its donor methyl group. Residues appropriately positioned to make either hydrogen
bonding or van der Waals contact with AdoMet are shown. Carbon atoms/bonds are colored gray/white; sulfur, yellow; nitrogen, blue; and
oxygen, red. The 13 potential hydrogen bonds whose lengths were in the range 2.5±3.3 AÊ are represented by dashed green lines. For clarity,
G68 (whose backbone carbonyl oxygen forms the near vertical hydrogen bond with the a-ammonium group of the AdoMet methionine moiety)
is not labeled. One of the three potential hydrogen bonds to the 39 OH of the AdoMet ribose is almost completely hidden in the view shown.
structure, possessing an average temperature factor of G199 and D223 in alcohol dehydrogenase), where the
acidic residue hydrogen bonds with the hydroxyls of the18.6 AÊ 2 (in comparison with an average of 28 AÊ 2 for the
overall structure). AdoMet appears to be firmly held by NAD adenosine ribose (Eklund et al., 1981).
AS11, via a network of 13 hydrogen bonds plus a number
of potential van der Waals contacts (Figure 4). The Ado- Relationship of the Structure to the
Methyltransferase Activity of VP39Met±binding site comprises a shallow pocket in the pro-
tein envelope, denying most of the AdoMet molecule By mutagenesis combined with functional assays, sev-
eral regions of VP39 important specifically for its methyl-contact with solvent. The edge of the AdoMet adenine
transferase activity have been identified (Schnierle etring comprising atoms N6, N7, and C8 peers out from
al., 1994; Shi et al., 1996). For several of the methyltrans-one end of the AdoMet±binding pocket, and the donor-
ferase-deficient mutants, substrate binding defectsmethyl group protrudes from the pocket toward the
have been identified that account for their lack of methyl-center of the cleft. The position of AdoMet (at the C
transferase activity (Shi et al.,1996). Thus, three mutantstermini of strands b1 and b2) is equivalent to its posi-
exhibiting defects in binding to the terminal (m7G) nucle-tion in M. TaqI (Labahn et al., 1994) and COMT
otide of the 59 cap 0 structure contain substitutions in(Vidgren et al., 1994) and to the position of bound
the region between residues 32 and 46 (Shi et al., 1996).S-adenosylhomocysteine (AdoHcy) in the M. HhaI±DNA
This region covers the N-terminal end of helix a2 andcomplex (Klimasauskas et al., 1994). In addition, several
the loop just preceding it, adjacent to the methionineof the specific contacts between VP39 and AdoMet are
moiety of the bound AdoMet molecule (Figure 1). Thecomparable to cofactor contacts made by the other
portion of the protein surface derived from residuesthree structurally defined methyltransferase/cofactor
32±46 is colored yellow in Figures 3D and 3E.complexes (summarized in Table 1). Most notable is the
conservation of a small residue (G68 in VP39) at the end The segment of VP39 between residues 138 and
of a b strand (b1 in VP39) juxtaposed to an acidic residue 150 was identified as important for AdoMet binding and
(D95 in VP39) at the end of an adjacent strand (b2 in possibly also for methyltransferase catalytic function
VP39). Such residues are found in equivalent positions (Shi et al., 1996). The VP39 mutant AS10, in which D138
at the nicotinamide adenine dinucleotide (NAD)±binding and R140 are substituted with alanines, exhibited wild-
type RNA binding behavior including the characteristicsites of all structurally defined dehydrogenases (e.g.,
3-D Structure of Vaccinia mRNA Modifying Enzyme
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Table 1. AdoMet±Protein Interactions Conserved in Methyltransferasesa
Equivalent Residues in Methyltransferases
Location in
VP39 Consensus Fold
AdoMet Interaction (AS11) COMT M. HhaI M. TaqI (Figure 2A)
Backbone N H-bond to terminal
carboxyl oxygen G72 G71 G23 NCb Beginning of helix A
Sidechain H-bonds to ribose
O29 and O39 D95 E90 E40 E71 End of strand 2
Small residue juxtaposed with
the above acidic residue G68 G68 A19 A48 End of strand 1
Backbone or side chain H-bond
to adenine N6 V116 S119 D60 D89 Beginning of helix C
vdw contact with face of adenine V116 NC I61 F90 Beginning of helix C
a Elements of this table are taken from Table 1 in Schluckebier et al., 1995.
b Not conserved.
cap 0±dependent enhancement of RNA±protein associ- In the AS11±AdoMet cocrystal structure, the backbone
nitrogen of residue 140 is hydrogen bonded to O49 ofation rate, but was unique among all of the mutants in
being completely deficient in AdoMet binding (Shi et al., the AdoMet ribose (Figure 4). If the backbone of R140
adopts a similar conformation in wild-type VP39, then1996). Since the R140A substitution in a different VP39
mutant (AS11) did not abrogate AdoMet binding, the the arginine side chain would extend into the cleft very
close to the position where the AdoMet donor methylcarboxylate side chain of D138 (the only moiety removed
from residue 138 by alanine substitution) was implicated group emerges from the AdoMet-binding pocket (Figure
4). R140 might therefore have a role in correctly position-as the sole cause of the AdoMet binding defect. It is
notable, therefore, that this carboxylate makes salt link ing the ribose moiety of the substrate nucleotide for
methyl transfer. An intriguing explanation for the ele-and hydrogen bonding interactions with the a-ammo-
nium nitrogen of the AdoMet methionine moiety in the vated AdoMet binding activity of AS11 with respect to
that of wild-type VP39 might be provided by the loss, duecocrystal structure (Figure 4). This apparently comprises
the only salt link between the protein and AdoMet, and to the R140A substitution, of an electrostatic repulsion
between the positively charged arginine 140 side chainits apparent importance isunderscored by the functional
data. The other residues that apparently interact with and the like-charged AdoMet sulfur. An electrostatic
repulsion between AdoMet and the wild-type enzymeAdoMet in the cocrystal structure had not been mutated
previously (Schnierle et al., 1994; Shi et al., 1996), so would also be consistent with the low Ki observed for
AdoHcy, a product of the methyltransferase reactiontheir importance cannot be ascertained.
The methyltransferase active site is defined by the with a neutral sulfur atom (Barbosa and Moss, 1978).
The other two substitutions in AS11, namely K142A andposition of the AdoMet donor methyl group in the co-
crystal. This site appears to be vicinal to a patch of basic R143A, are located within the missing 142±147 loop in
the AS11 structure (see above). The positions of theresidues comprising the side chains of residues K41,
K175, and R209 (Figures 3A and 3D). The putative bind- loop endpoints (colored blue in Figures 3D and 3E) indi-
cate that, in AS11, loop residues are unlikely to contacting site for the terminal (m7G) nucleotide of the cap
(described above) is an appropriate distance from the AdoMet directly. An RNA-binding role for K142 and R143
in wild-type VP39 would be consistent with the RNAactive site for VP39 to simultaneously bind both the
terminal and penultimate (methyl-accepting) nucleo- binding defect of the mutant (see below).
In addition to the three cap binding±defective mutantstides of the cap, such that the ribose moiety of the latter
could be poised to accept the AdoMet methyl group. and mutants AS10 and AS11 (which have anomalous
AdoMet-binding properties as described above), theSince the basic region associated with the active site
appears to spread toward the binding site for m7G (Fig- substrate-binding properties of four additional methyl-
transferase-specific mutants have been analyzed (Shiures 3A and 3D), basic residues in this region might be
appropriately positioned for ionic interaction with the et al., 1996). Two of these (SS5 and AS17) possessed
an RNA binding defect. Since the other two (SS4 andtriphosphate bridge of the cap.
Two substrate binding defects have been detected in AS14) appeared to be wild-type in binding to AdoMet,
as well as to capped and uncapped RNA (Shi et al.,methyltransferase-defective mutant AS11 (the mutant
whose structure was determined here): an AdoMet bind- 1996), their primary lesions were not apparent. The sub-
stitutions of the SS5 variant are buried just under theing activity apparently greater than wild-type VP39 and
a very low affinity for both capped and uncapped RNA cleft surface. The surface positions of substitutions in
the remaining three mutants are colored green in Figures(Shi et al., 1996). AS11 contains three amino acid substi-
tutions: R140A, K142A, and R143A. Since residue 140 3D±3F, along with the positions of substitutions in an
additional specifically methyltransferase±defective mu-is the closest of the three to the active site, the R140A
substitution may be responsible for the increased affin- tant, AS1 (despite AS1 having not been subjected to
substrate-binding assays). Interestingly, substitutions inity of AS11 for AdoMet or for its catalytic defect, or both.
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pocket. The distance from the AdoMet donor methyl to
the distal end of the hydrophobic pocket (near F22) is
z25 AÊ . As illustrated in Figure 5, this distance could
accommodate z5 nucleotides of single-stranded oligo-
nucleotide if bases are unstacked as in DNA that is
complexed with gene 32 protein (gp32) in the cocrystal
(z5 AÊ per nucleotide; Shamooet al., 1995), or z7 nucleo-
tides if the bases are stacked with one another (assum-
ing an internucleotide distance of z3.5 AÊ ). The binding
to VP39 of RNA nucleotides in addition to the cap is
consistent with the inability of VP39 to methylate a cap
structure that is not attached to an RNA chain (Barbosa
and Moss, 1978).
Substitutions in two of the green mutants (above) lie
well away from the cleft, either on the flat face or strad-
dling the edge of the protein between this face and the
distal end of the cleft (Figures 3D±3F). Furthermore, one
of these mutants (AS17) is strongly defective in overall
RNA binding (Shi et al., 1996). These observations
strongly suggest an interesting possibility, namely that
the methyltransferase reaction requires its substrate
RNA to track around the surface of VP39 beyond the
distal end of the cleft.
Figure 5. Schematic Showing a Model for the Binding of a 59-
Capped RNA Strand to the Cleft and Methyltransferase Active Site
Novel Architecture for an RNA-Binding DomainThe cleft is viewed from an angle similar to that in Figures 3A, 3D,
Comparison of VP39 with the three-dimensional struc-and 3G. Important regions of the surface are labeled, including the
putative binding site for the terminal (m7G) nucleotide of cap 0 (cap tures of other RNA-binding proteins indicates that VP39
binding); the position at which the donor methylof AdoMet protrudes has a novel architecture for an RNA-binding protein.
into the cleft (donor methyl); the active site and associated basic Except for the transfer RNA synthetases (Rould et al.,
region (basic region/active site); the missing 142±147 loop (which
1989; Ruff et al., 1991; Cavarelli et al., 1993; Belrhali etcontains basic side chains in wild-type VP39) and the hydrophobic
al., 1994; Biou et al., 1994) and the E. coli Rop proteinpocket at the distal end of the cleft. RNA nucleotides arerepresented
(Banner et al., 1987; Predki et al., 1995), all of the RNA-by dark ovals. An internucleotide spacing of z5 AÊ per base was
used, based upon the spacing determined for single-stranded DNA binding proteins whose structures are currently known
bound to gp32 (in which DNA bases were unstacked; Shamoo et possess a/b folds, in which a relatively flat platform b
al., 1995). strands is packed against a pair of a helices on one
side and solvent exposed on the other. These proteins
include the RNP domain-containing proteins (GoÈ rlacheach of the indicated ªgreenº mutants (except for AS1)
lie within or close to the cleft (Figures 3D and 3E), et al., 1992; Wittekind et al., 1992; Oubridge et al., 1994),
the KH module (Morelli et al. 1995), the dsRNA-bindingstrongly implicating the whole cleft region in the methyl
transfer reaction. However, confirmation of this must domain (Bycroft et al., 1995; Kharrat et al. 1995), the cold
shock proteins (Schindelin et al., 1993, 1994), ribosomalawait an RNA±protein cocrystal structure.
All of the above data clearly suggest how a 59 cap proteins (Leijonmarck et al., 1980; Wilson et al., 1986;
Lindahl et al., 1994), the phage MS2 coat protein (Vale-0±terminated RNA oligonucleotide (i.e., a methyltrans-
ferase substrate) might bind VP39. As shown schemati- gaÂ rd et al., 1994), and the phage T4 regA protein (Kang
et al., 1995). Typically, the solvent-exposed surface con-cally in Figure 5, the substrate oligonucleotide can be
arranged into thecleft guided by the cap binding site, the tains a conserved arrangement of phenylalanines and
tyrosines with nearby patches of basic residues. Struc-methyltransferase active site, the missing (RNA binding)
loop, and the hydrophobic pocket. In this model, the tural studies of RNA±protein complexes confirm that
solvent-exposed aromatic side chains attached to theterminal (m7G) nucleotide of the type 0 cap interacts
with its putative binding site. m7G is linked via the tri- b-sheet stack with the RNA bases (GoÈ rlach et al., 1992;
Oubridge et al., 1994; ValegaÂ rd et al., 1994). Further-phosphate bridge of the cap to the penultimate nucleo-
tide of the cap (labeled N1), whose ribose moiety is more, structural studies of sequence-nonspecific nu-
cleic acid±binding proteins, namely adenovirus DNA±positioned at the active site. The first three transcribed
nucleotides of the RNA chain (labeled N1±N3) are pro- binding protein (Tucker et al., 1994), gene V protein from
the phage f1 (Skinner et al., 1994), and gp32 from T4posed to be bound nonspecifically within the central
region of the cleft, perhaps by hydrogen bonding or cocrystalized with DNA (Shamoo et al., 1995), also show
a pattern of single-stranded nucleic acid±binding viaelectrostatic interaction of the RNA sugar-phosphate
backbone with basic regions present at the active site solvent-exposed b sheets. Although VP39 shares sur-
face features with other RNA and single-stranded nu-and within the missing loop (or both). The two subse-
quent nucleotides (labeled N4 and N5) could be bound cleic acid±binding proteins (above), these features ap-
pear to be supported by a fundamentally differentat the distal end of the cleft, in a sequence-nonspecific
manner, with their bases buried in the hydrophobic protein architecture: the b sheet of VP39 is positioned
3-D Structure of Vaccinia mRNA Modifying Enzyme
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within the protein core, almost completely sequestered VP39 methylation. As with COMT (Vidgren et al., 1994),
the methylation target of VP39 is a hydroxyl oxygen.from solvent (Figures 1 and 3G±3I), and nearly the entire
surface of VP39 is formedby loops and a helices (Figures However, unlike COMT, VP39 does not require an Mg21
for methyltransferase activity.1 and 3G±I). This would indicate that it is the loops and
helices, rather than a b sheet, which support the RNA-
contacting side chains of VP39. A Putative Second RNA-Binding Site Remote
from the Methyltransferase Cleft
Exposed aromatic side chains juxtaposed with basicEvolution
ones feature prominently on the face of VP39 oppositeThe VP39±AdoMet cocrystal structure provides a proto-
that containing the cleft (i.e., the flat face; Figure 3C).typic structure of an intact poxvirus protein, though the
This arrangement suggests an RNA-binding function,structure of a fragment of vaccinia topoisomerase has
due to the prominence of such features on the sur-been reported (Sharma et al., 1994). Comparison of the
faces of various unrelated RNA-binding and sequence-VP39 structure with that of other methyltransferases
nonspecific nucleic acid±binding proteins (above). Theindicates that, in this instance, vaccinia has not evolved
flat face may therefore contain a second putative RNA-a completely independent structural solution to an im-
binding site (labeled Site B in Figure 3C). The absenceportant catalytic function. Instead, an old fold has appar-
of pocket-like features on the flat face might not beently learned new tricks. The overall fold of VP39 sug-
disadvantageous if the aromatic amino acid side chainsgests its evolution from an ancestral fold shared
are able to stack with RNA bases. The flat face of VP39between diverse methyltransferases, through the addi-
is formed, in part, from the region C-terminal to the coretion of structures required for its RNA 59 and mRNA 39
structure of the protein (i.e., helices a7, a8, and a9).end±modifying activities. Each of the three structurally
When expressed as a truncation fragment, this segmentdefined DNA methyltransferases, M. HhaI, M. HaeIII, and
of VP39 (plus the invisible C-terminal tail) has been re-M. TaqI, has evolved a second domain that functions in
ported to retain nearly wild-type levels of RNA bindingsubstrate recognition and binding and that also plays a
in a nitrocellulose filter RNA binding assay (Schnierle etrole in base flipping (Klimasauskas et al., 1994; Labahn
al., 1994). Consistent with its observed RNA bindinget al., 1994; Cheng, 1995; Reinisch et al., 1995; Roberts,
activity, this region also contains nearly 50% of the pro-1995). The single domain architecture of VP39 is more
tein's 35 phenylalanine and tyrosine residues (Shi etreminiscent of the small molecule methyltransferase,
al., 1996). However, inspection of the crystal structureCOMT, than the bacterial DNA methyltransferases.
indicates that 9 of the C-terminal segment's 15 phenylal-Thus, instead of acquiring an additional, discrete do-
anine and tyrosine residues are inaccessible to solvent,main for RNA substrate recognition, VP39 appears to
eliminating them from a role in RNA binding in the ab-have customized a methyltransferase catalytic domain,
sence of substantial conformational rearrangement. Aby both incorporating the necessary surface features
clear characterization of the roles of residues on the flatinto it and appending short N- and C-terminal segments.
face of VP39 will require additional mutagenesis and/orSpecifically, the loop connecting strands b5 and b6 of
functional studies.VP39, the only region in which the architecture of the
If site B is indeed an RNA-binding site, what is itscentral VP39 core deviates from the consensus methyl-
role? It is possible that the binding site for the methyl-transferase fold, comprises one side of the cleft con-
transferase substrate RNA, which possibly extends be-taining the methyltransferase active site. Furthermore,
yond the distal end of the cleft (above), tracks all thethe short N- and C-terminal appendages to the VP39
way to site B. An additional possibility would be thatcore contribute to both of its putative RNA-binding sites.
site B plays a role in the adenylyltransferase-stimulatoryThe apparent architectural efficiency of the VP39 design
activity of VP39 if it is presumed, as is likely, that directmay be a reflection of its evolution within the context
RNA contact is necessary for the action of VP39 as aof an organism with a rapid generation time. Despite its
poly(A) polymerase processivity factor. Indeed, site Bactivity in increasing the processivity of a polymerase,
may be the only strong candidate RNA-binding site forVP39 appears to be completely unrelated in structure
adenylyltransferase-stimulatory function of VP39, sinceto theDNA polymerase processivity factors (Kuriyan and
mutations in and around the methyltransferase cleft (thisO'Donnell, 1993).
cleft being the only other likely candidate) apparently
do not abrogate adenylyltransferase-stimulatoryactivity
Mechanism of the Methyl Transfer Reaction (Shi et al., 1996; this study).
A mechanism for methyltransferase catalysis has been
proposed for the cytosine C5 methyltransferases (Wu
Experimental Proceduresand Santi, 1987), the structures of two of which are now
known (Cheng et al., 1993, Reinisch et al., 1995). By this Sample Preparation
mechanism, methylation of the cytosine aromatic ring The plasmid encoding AS11 was provided by B. Schnierle and B.
Moss. For AS11 expression as a glutathione transferase fusion pro-is initiated by attack of a conserved cysteine sulfur±
tein, E. coli strain HB101 was transformed with this plasmid. A 100hydrogen group upon a ring carbon (Wu and Santi,
ml culture of transformed cells in superbroth containing 100 mg/l1987). Such a mechanism could not be not applicable to
ampicillin was grown to stationary phase, then used to inoculate aVP39, since the two cysteines of the protein are neither
14 l culture of superbroth/ampicillin. After growth of the 14 l culture
required for methyltransferase activity (Schnierle et al., to stationary phase at 378C, in a fermentor with aeration, isopropyl-
1994) nor close to the methyltransferase active site (this b-D-thiogalactopyranoside (0.5 mM final concentration) was added
and the culture maintained for an additional 3±4 hr. Cells were thenstudy). Moreover, an aromatic ring is not the target of
Cell
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Table 2. Data Collection and Phasing Statistics
Native HgCl2 PtCl4 KAuCN2 EtHgCl
Resolution (AÊ ) 1.85 2.0 2.0 2.5 2.0
Observations 208238 169680 170299 79841 156217
Unique reflections 33404 19333 21466 13236 22926
Completeness 98% 71% 79% 95% 84%
Rsymma 5.0% 6.2% 6.5% 8.5% 7.3%
No. sites/new sites 1/1 1/1 1/1 3/1b
Phasing to 3AÊ
Rcentricc 0.59 0.71 0.60 0.63
Phasing Powerd 1.6 1.6 1.7 1.5
,FOM.e (all) 0.76
aRsymm 5 oh,k,l o
n
i 5 1
|I(h,k,l)i2kI(h,k,l)l|/oh,k,lo
n
i51
I(h,k,l).
b One site shared with HgCL2. A second site shared with KAuCN2.
c Rcentric 5 oh,k,l|Fh,obs (h,k,l)2Fh,calc (h,k,l)|/oh,k,l Fh,obs (h,k,l) for centric reflections only.
d Phasing power 5 Fh/e, where Fh is the heavy atom structure factor amplitude and e is the residual lack-of-closure error.
e ,FOM. 5 figure of merit defined as cosks(Dw)l
harvested by centrifugation and the resulting cell pellet (80 g wet KAu(CN)2, and Ethyl HgCl. From these four derivatives, an interpret-
able solvent-flattened multiple isomorphous replacement withweight) was suspended in 150 ml of extraction buffer (20 mM
HEPES±NaOH (pH 7.5), 0.1 M NaCl, 1 mM 2-mercaptoethanol, 0.1% anomalous scattering (MIRAS) map (<m> 5 0.76) was computed to
3 AÊ (see Table 2). Heavy atom parameter refinement, phase calcula-Nonidet P-40 [NP-40], 10% glycerol). After 2 min sonication at high
power with 50% duty cycle, the broken cell suspension was clarified tion, and solvent flattening were performed using the PHASES pack-
age (Furey and Swaminathan, 1990). Of the protein molecule, 70%by centrifugation and the pellet resonicated in 150 ml of extraction
buffer and recentrifuged. was built into the MIRAS map using the program CHAIN (Sack, 1988)
with an initial R-factor of 40%. From this model, a sA±weighted 2Fo -Glutathione-sepharose (20 ml packed bead volume; Pharmacia)
was added to the 300 ml combined supernatants, and the resulting Fc map was calculated using the program SIGMAA (Read, 1986).
After several rounds of rebuilding, refinement, and recalculation ofmixture was incubated at 48C for 30 min with inversion. The beads
were then pelleted by centrifugation, washed three times with 80 the map using data to 2 AÊ and the XPLOR program (BruÈ nger, 1992),
290 of the 333 protein residues were modeled with anml of extraction buffer, and resuspended in 40 ml total of extraction
buffer. The resulting slurry was supplemented with CaCl2 (2.5 mM) R-factor of 27%. The model was missing the C-terminal 36 residues
and the region between residues 142 and 147, containing the tripleand incubated with thrombin (30 U, Novagen) at 258C for 4 hr, then
overnight at 48C. Supernatant containing the AS11 moiety was de- mutation. At this stage, strong clear density near the missing loop
was recognized as a molecule of S-adenosylmethionine. This mole-canted from the settled beads, which were then washed three times
with 60 ml aliquots of extraction buffer. cule was added to the model and the structure was then refined to
1.85 AÊ . Water molecules (n 5 203) were added to the model, whichThe four fractions containing eluted AS11 protein were pooled,
diluted with an equal volume of H2O, and bound to a 5 ml heparin was then refined to a final R-factor of 21.5% and a free R-factor of
25%. The final structure exhibits good geometry with rms bondagarose column (HiTrap, Pharmacia). After washing the column ex-
haustively with buffer comprising 10 mM Tris-HCl (pH 8.0), 1 mM deviations of 0.01 AÊ and rms angle deviations of 1.778. The overall
temperature factor was 28.6 AÊ 2 in agreement with the Wilson plot.2-mercaptoethanol, and 10% glycerol, to remove all traces of the
NP-40 detergent, bound protein was eluted with a linear gradient
of 0±500 mM NaCl in the column wash buffer. Fractions containing Acknowledgments
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